159 related articles for article (PubMed ID: 3036721)
21. Effects of chemical inducers on the Epstein-Barr virus cycle in epithelial/nasopharyngeal carcinoma hybrid cell line.
Takimoto T; Ishiguro H; Umeda R; Ogura H; Hatano M
ORL J Otorhinolaryngol Relat Spec; 1984; 46(4):192-4. PubMed ID: 6087237
[TBL] [Abstract][Full Text] [Related]
22. Differential effect of TPA and n-butyrate on induction of Ii and EBV antigens in the P3HR-1 lymphoblastoid cell line.
Sairenji T; Spiro RC; Humphreys RE
Hematol Oncol; 1984; 2(4):381-9. PubMed ID: 6098544
[TBL] [Abstract][Full Text] [Related]
23. Induction of Epstein-Barr virus antigens by hydroxyurea.
Nováková Z; Roubal J
Acta Virol; 1988 Mar; 32(2):160-3. PubMed ID: 2899964
[TBL] [Abstract][Full Text] [Related]
24. N-methyl-N'-nitro-N-nitrosoguanidine induces and cooperates with 12-O-tetradecanoylphorbol-1,3-acetate/sodium butyrate to enhance Epstein-Barr virus reactivation and genome instability in nasopharyngeal carcinoma cells.
Huang SY; Fang CY; Tsai CH; Chang Y; Takada K; Hsu TY; Chen JY
Chem Biol Interact; 2010 Dec; 188(3):623-34. PubMed ID: 20869957
[TBL] [Abstract][Full Text] [Related]
25. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns.
Klein G; Zeuthen J; Ber R; Ernberg I
J Natl Cancer Inst; 1982 Feb; 68(2):197-202. PubMed ID: 6278188
[TBL] [Abstract][Full Text] [Related]
26. [Suppressive effect of CDDP on induction of the Epstein-Barr virus antigen synthesis by n-butyrate].
Furukawa M; Kato C; Kamide M; Umeda R
Nihon Jibiinkoka Gakkai Kaiho; 1989 Feb; 92(2):189-93. PubMed ID: 2545850
[TBL] [Abstract][Full Text] [Related]
27. Induction of Epstein-Barr virus in B-lymphoblastoid cells by human immunodeficiency virus type 1.
Lai PK; Li X; Volsky DJ
Int J Cancer; 1989 Jun; 43(6):1104-11. PubMed ID: 2543643
[TBL] [Abstract][Full Text] [Related]
28. Activation of the EBV-cycle and aggregation of human blood lymphocytes by the tumor promoters teleocidin, lyngbyatoxin A, aplysiatoxin and debromoaplysiatoxin.
Eliasson L; Kallin B; Patarroyo M; Klein G; Fujiki H; Sugimura T
Int J Cancer; 1983 Jan; 31(1):7-11. PubMed ID: 6299973
[TBL] [Abstract][Full Text] [Related]
29. Suppression by protein kinase C inhibitors of tumor promoter enhancement of Epstein-Barr virus-induced growth transformation.
Kinoshita T; Takahashi I; Kobayashi E; Tamaoki T; Irie K; Koshimizu K; Osato T
Anticancer Res; 1990; 10(4):1051-4. PubMed ID: 1696445
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus-induced proteins. IV. Characterization of an EBV-associated phosphopolypeptide.
Mueller-Lantzsch N; Yamamoto N
J Gen Virol; 1981 Aug; 55(Pt 2):333-41. PubMed ID: 6270267
[TBL] [Abstract][Full Text] [Related]
31. Productive infection of Epstein-Barr virus (EBV) in EBV-genome-positive epithelial cell lines (GT38 and GT39) derived from gastric tissues.
Takasaka N; Tajima M; Okinaga K; Satoh Y; Hoshikawa Y; Katsumoto T; Kurata T; Sairenji T
Virology; 1998 Aug; 247(2):152-9. PubMed ID: 9705908
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus-activating principle in human semen.
Ito Y; Tokuda H; Morigaki T; Shimizu K; Kawana T; Sanada S; Yoshida O
Cancer Lett; 1984 Jun; 23(2):129-34. PubMed ID: 6331637
[TBL] [Abstract][Full Text] [Related]
33. Alkaline deoxyribonuclease induced with diterpene ester TPA and n-butyrate in Epstein-Barr virus genome-carrying Raji cells.
Kawanishi M; Ito Y
Intervirology; 1985; 23(1):55-60. PubMed ID: 2982761
[TBL] [Abstract][Full Text] [Related]
34. Immunofluorescence microscopy and flow cytometry characterization of chemical induction of latent Epstein-Barr virus.
Jenson HB; Grant GM; Ench Y; Heard P; Thomas CA; Hilsenbeck SG; Moyer MP
Clin Diagn Lab Immunol; 1998 Jan; 5(1):91-7. PubMed ID: 9455888
[TBL] [Abstract][Full Text] [Related]
35. Relationship between Epstein-Barr virus nuclear antigen and DNA genome number in superinfected and induced lymphoblastoid cell lines.
Boguszaková L; Hirsch I; Brichácek B; Vonka V
J Gen Virol; 1983 Apr; 64 (Pt 4)():887-94. PubMed ID: 6300308
[TBL] [Abstract][Full Text] [Related]
36. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines.
Anisimová E; Saemundsen AK; Roubal J; Vonka V; Klein G
J Gen Virol; 1982 Jan; 58 Pt 1():163-71. PubMed ID: 6292341
[TBL] [Abstract][Full Text] [Related]
37. Cocaine potentiates the switch between latency and replication of Epstein-Barr virus in Raji cells.
Di Francesco P; Lisi A; Rieti S; Manni V; Grimaldi S; Garaci E
Biochem Biophys Res Commun; 1999 Oct; 264(1):33-6. PubMed ID: 10527836
[TBL] [Abstract][Full Text] [Related]
38. Comparative studies of herpesvirus papio (baboon herpesvirus) DNA and Epstein-Barr virus DNA.
Lee YS; Tanaka A; Lau RY; Nonoyama M; Rabin H
J Gen Virol; 1980 Dec; 51(Pt 2):245-53. PubMed ID: 6262436
[TBL] [Abstract][Full Text] [Related]
39. Detection of tumor promoters by early antigen expression of EB virus in Raji cells using a fluorescence microplate-reader.
Ohmori K; Miyazaki K; Umeda M
Cancer Lett; 1998 Oct; 132(1-2):51-9. PubMed ID: 10397453
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of Epstein-Barr virus membrane protein (LMP) expression by serum, TPA, or n-butyrate in latently infected Raji cells.
Boos H; Berger R; Kuklik-Roos C; Iftner T; Mueller-Lantzsch N
Virology; 1987 Jul; 159(1):161-5. PubMed ID: 3037776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
